Biographical Info

Dr. Radbel is Assistant Professor in the Rutgers Robert Wood Johnson Medical School.  He is a pulmonary and critical Care physician, who specializes in the treatment of patients with acute respiratory distress syndrome (ARDS).  He is a member of Rutgers Environmental and Occupational Health Sciences Institute and the Rutgers NJ Alliance for Clinical and Translational Science (NJACTS) Society of Scholars.

Education

• Pulmonary and Critical Care Fellowship, Rutgers Robert Wood Johnson Medical School
• Internal Medicine Residency, Staten Island University Hospital
• MD, American University of the Caribbean School of Medicine
• BA, State University of New York (SUNY) at Binghamton

Research Areas

Ozone is a ubiquitous urban air pollutant that has been directly linked to the development of the heavily morbid acute respiratory distress syndrome (ARDS).  Dr. Radbel is currently funded by an NIEHS K08 Mentored Clinical Scientist Development Award (K08ES031678) to study the role of macrophage efferocytosis in ozone-induced ARDS.  He works in the laboratories of his mentors Debra L. Laskin PhD and Andrew J. Gow PhD. During the COVID-19 pandemic, he served as the Rutgers Robert Wood Johnson Medical School site PI for the multicenter Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 (STOP-COVID) database.

Scholarly Activities

• Environmental Health Policy Committee Member, American Thoracic Society (ATS), May 2023-May 2024
• Planning Committee Member, Environmental, Occupational and Population Health (EOPH) assembly of the American Thoracic Society (ATS), May 2023 – May 2024
• Programming Committee Member, Environmental, Occupational and Population Health (EOPH) assembly of the American Thoracic Society (ATS), May 2018 – May 2023

In the News

• In 2023, Dr. Radbel was selected as an Honorable Mention in the Society for Leukocyte Biology Image Contest
• In 2020, Dr. Radbel was awarded the Career Development Award by the Rutgers NIEHS CEED. Jan 2020
• In 2018, Dr. Radbel was awarded Donald E. Gardner Inhalational Toxicology Education Award by the Society of Toxicology
• In 2014, Dr. Radbel was awarded the Young Investigator Award by the American College of Chest Physicians.

1. Engels, SH, Mergen, AC, Nassikas, N, Radbel, J. The Supreme Court’s Shadowy Treatment of Public Health. N Engl J Med. 2024; :. doi: 10.1056/NEJMp2408380. PubMed PMID:39231314
2. Radbel, J, Rebuli, ME, Kipen, H, Brigham, E. Indoor air pollution and airway health. J Allergy Clin Immunol. 2024;154 (4):835-846. doi: 10.1016/j.jaci.2024.08.013. PubMed PMID:39182629
3. Radbel, J, Meshanni, JA, Vayas, KN, Le-Hoang, O, Abramova, E, Zhou, P, Joseph, LB, Laskin, JD, Gow, AJ, Laskin, DL et al.. Effects of ozone exposure on lung injury, inflammation, and oxidative stress in a murine model of nonpneumonic endotoxemia. Toxicol Sci. 2024;200 (2):299-311. doi: 10.1093/toxsci/kfae062. PubMed PMID:38749002 PubMed Central PMC11285192
4. Radbel, J, Meshanni, JA, Gardner, CR, Le-Hoang, O, Cervelli, J, Laskin, JD, Gow, AJ, Laskin, DL. Novel method to assess resident alveolar macrophage efferocytosis of apoptotic neutrophils by flow cytometry. Toxicol Appl Pharmacol. 2023;460 :116359. doi: 10.1016/j.taap.2022.116359. PubMed PMID:36565939 PubMed Central PMC9870943
5. Sunil, VR, Vayas, KN, Radbel, J, Abramova, E, Gow, A, Laskin, JD, Laskin, DL. Impaired energy metabolism and altered functional activity of alveolar type II epithelial cells following exposure of rats to nitrogen mustard. Toxicol Appl Pharmacol. 2022;456 :116257. doi: 10.1016/j.taap.2022.116257. PubMed PMID:36174670
6. Datta, P, Ukey, R, Bruiners, N, Honnen, W, Carayannopoulos, MO, Reichman, C, Choudhary, A, Onyuka, A, Handler, D, Guerrini, V et al.. Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination. J Immunol Methods. 2021;499 :113165. doi: 10.1016/j.jim.2021.113165. PubMed PMID:34634317 PubMed Central PMC8500840
7. Churpek, MM, Gupta, S, Spicer, AB, Hayek, SS, Srivastava, A, Chan, L, Melamed, ML, Brenner, SK, Radbel, J, Madhani-Lovely, F et al.. Machine Learning Prediction of Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Explor. 2021;3 (8):e0515. doi: 10.1097/CCE.0000000000000515. PubMed PMID:34476402 PubMed Central PMC8378790
8. Datta, P, Ukey, R, Bruiners, N, Honnen, W, Carayannopoulos, MO, Reichman, C, Choudhary, A, Onyuka, A, Handler, D, Guerrini, V et al.. Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection. medRxiv. 2021; :. doi: 10.1101/2021.07.09.21260266. PubMed PMID:34282427 PubMed Central PMC8288160
9. Douin, DJ, Shaefi, S, Brenner, SK, Gupta, S, Park, I, Wright, FL, Mathews, KS, Chan, L, Al-Samkari, H, Orfanos, S et al.. Tissue Plasminogen Activator in Critically Ill Adults with COVID-19. Ann Am Thorac Soc. 2021;18 (11):1917-1921. doi: 10.1513/AnnalsATS.202102-127RL. PubMed PMID:33872546 PubMed Central PMC8641829